Nicotine intake in smokers increases following a single dose of haloperidol
Psychopharmacology - 1995
Tóm tắt
The effects of oral haloperidol on nicotine intake, subjective measures of craving and smoking satisfaction were compared with placebo in light-to-moderate smokers from a post-prandial cigarette and during the subsequent hour of unrestricted smoking. Subjects smoked significantly more, as measured by blood nicotine levels, when they had received haloperidol, although there was no difference between haloperidol and placebo an any subjective measures. These findings may be interpreted to reflect a compensatory increase in smoking in order to obtain the usual nicotine reward. Having achieved usual levels of reward, subjects did not experience a decrease in subjective measures of smoking satisfaction or an increase in nicotine craving.
Từ khóa
Tài liệu tham khảo
Anderson BG, Reker D, Cooper TB (1981) Prolonged adverse effects of haloperidol in normal subjects. N Engl J Med 11:643–644
Baldessarini RJ (1985) Drugs and the treatment of psychiatric disorders. In: Gilman AG, Goodman L, Rall TW, Murad F (eds) Goodman and Gilman's The pharmacological basis of therapeutics. Macmillan NewYork
Baxter LR, Schwartz JM, Phelps M, Mazziotta J, Barrio J, Rawson R, Engel J, Guze B, Selin C, Sumida R (1988) Localisation of neurochemical effects of cocaine and other stimulants in the human brain. J Clin Psychol 49:23–26
Benowitz NL, Porchet H, Jacob P (1990) Pharmacokinetics, metabolism and pharmacodynamics of nicotine. In: Wonnacott S, Russell, MAH, Stolerman IP (eds) Nicotine psychopharmacology: molecular, cellular and behavioural aspects. Oxford University Press, Oxford
Brazell MP, Mitchell SN, Joseph MH, Gray JA (1990) Acute administration of nicotine increases thein vivo extracellular levels of dopamine, 3,4-dihydroxyphenylacetic acid and ascorbic acid preferentially in the nucleus accumbens of the rat: comparison with caudate putamen. Neuropharmacology 29:1177–1185
Corrigall WA, Coen KM (1991) Selective dopamine antagonists reduce nicotine self-administration. Psychopharmacology 104:171–176
Di Chiara G, Imperato A (1988) Drugs abused by humans preferentially increase synaptic dopamine concentration in the mesolimbic system of freely moving rats. Proc Nat Acad Sci USA 85:5274–5278
Fagerstrom K, Schneider NG (1989) Measuring nicotine dependence: a review of the Fagerstrom Tolerance Questionnaire. J Behav Med 12:159–182
Farde L, Wiesel AJ, Nordstrom AL, Sedvall G (1989) D1 and D2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics. Psychopharmacology 99:528–531
Feyerabend C, Russell MAH (1990) A rapid gas-liquid chromatographic method for the determination of cotinine and nicotine in biological fluids. J Pharm Pharmacol 42:450–452
Gawin FH (1986) Neuroleptic reduction of cocaine induced paranoia but not euphoria. Psychopharmacologia 90:142–143
Gunne LM, Angaard E, Jonsson LE (1972) Clinical trials with amphetamine-blocking drugs. Psychiatr Neurol Neurochir 75:225–226
Haertzen CA, Hickey JE (1987) Addiction Research Centre Inventory (ARCI): measurement of euphoria and other drug effects. In: Bozarth MA (ed) Methods of assessing the reinforcing properties of abused drugs. Springer, New York Berlin Heidelberg
Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom K (1991) The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict 86:1119–1127
Henningfield JE, Griffiths RR (1981) Cigarette smoking and subjective response: effects ofd-amphetamine. Clin Pharmacol Ther 30:497–505
Hughes JR, Hatsukami DK (1986) Signs and symptoms of tobacco withdrawal. Arch Gen Psychiatry 43:289–294
Jarvik M, Killen JD, Varady A, Fortman SP (1993) The favourite cigarette of the day. J Behav Med (in press)
Jarvis M, Tunstall-Pedoe H, Feyerabend C, Vesey C, Saloojee Y (1984) Biochemical markers of smoke absorption and self-reported exposure to passive smoking. J Epidemiol Community Health 38:335–339
Katz JL (1989) Drugs as reinforcers: pharmacological and behavioural factors. In: Liebman JM, Cooper SJ (eds) The neuropharmacological basis of reward. Clarenden Press, Oxford
Koob GF, Goeders NE (1989) Neuroanatomical substrates of drug self-administration. In: Liebman JM, Cooper SJ (eds) The neuropharmacological basis of reward. Clarenden Press, Oxford
Langone JJ, Van Vunakis H, Hill P (1975) Quantification of cotinine in sera of smokers. Res Commun Chem Pathol Pharmacol 10:21–28
London ED, Casella NG, Wong DF, Phillips RL, Dannals RF, Links JM, Herning R, Grayson R, Jaffe JH, Wagner HN (1990) Cocaine-induced reduction of glucose utilisation in human brain. Arch Gen Psychiatry 47:567–574
Nemeth-Coslett R, Henningfield JE, O'Keefe MK, Griffiths RR (1986) Effects of mecamylamine on human cigarette smoking and subjective ratings. Psychopharmacology 88:420–425
Nordstrom AL, Farde L, Hallin C (1992) Time course of D2-dopamine receptor occupancy examined by PET after single oral doses of haloperidol. Psychopharmacology 106:433–438
Nurnberger J I, Simmons-Alling S, Kessler L, Jimerson S, Schreiber J, Hollander E, Tamminga CA, Nadi NS, Goldstein DS, Gershon ES (1984) Separate mechanisms for behavioral, cardiovascular and hormonal responses to dextroamphetamine in man. Psychopharmacology 84:200–204
Pomerleau CS, Pomerleau OF, Majchrzak MJ (1987) Mecamylamine pretreatment increases subsequent nicotine self-administration as indicated by changes in plasma nicotine levels. Psychopharmacology 91:391–393
Russell MAH (1987) Nicotine intake and its regulation by smokers. In: Martin WR, Van Loon GR, Iwamoto ET, Davis L (eds) Tobacco smoking and nicotine. Plenum, NewYork
Russell MAH, Peto J, Pate UA (1974) The classification of smoking by factorial structure of motives. J R Stat Soc 137:313–333
Sherer MA, Kumor KM, Jaffe J (1989) Effects of intravenous cocaine are partially attenuated by haloperidol. Psychiatry Res 27:117–125
Stolerman IP, Goldfarb RF, Fink R, Jarvik ME (1973) Influencing cigarette smoking with nicotine antagonists. Psychopharmacologia 28:247–259
Taylor P (1980) Ganglionic stimulating and blocking agents. In: Gilman AG, Goodman LS (eds) The pharmacological basis of therapeutics, 6th edn. McMillan, New York
Tiffany ST, Drobes DJ (1991) The development and initial validation of a questionnaire on smoking urges. Br J Addict 86:1467–1476